Hikma Pharmaceutical | HIK - Equity Capital And Reserves

Stock Price
1,397.00
Daily Change
11.00 0.79%
Monthly
11.14%
Yearly
-28.76%
Q2 Forecast
1,361.73

Hikma Pharmaceutical reported $2.59B in Equity Capital and Reserves for its fiscal semester ending in December of 2025.





Equity Capital And Reserves Change Date
Almirall EUR 1.49B 24.03M Dec/2025
argenx SE USD 6.1B 597.47M Jun/2025
AstraZeneca USD 48.67B 2.78B Dec/2025
Autolus Therapeutics Ltd USD 178.13M 87.32M Dec/2025
Bayer EUR 25.95B 3.75B Dec/2025
Fresenius EUR 18.62B 320M Sep/2025
Galapagos EUR 3.24B 788.91M Dec/2025
Genmab DKK 5.85B 96M Dec/2025
GlaxoSmithKline GBP 16.38B 229M Dec/2025
GRIFOLS EUR 5.29B 108.05M Dec/2025
Hikma Pharmaceutical USD 2.59B 42M Dec/2025
Lonza CHF 9.13B 513M Dec/2025
Merck EUR 28.59B 344M Dec/2025
Orion EUR 1.12B 162.1M Mar/2026
Recordati EUR 1.93B 57.32M Sep/2025
Roche Holding CHF 33.8B 758M Dec/2025
Sanofi EUR 72.81B 1.1B Mar/2026
UCB EUR 10.87B 1.18B Dec/2025